We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+0.73%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$24.1B
AUM Growth
+$1.97B
Cap. Flow
+$2.04B
Cap. Flow %
8.47%
Top 10 Hldgs %
10.49%
Holding
3,709
New
1,117
Increased
953
Reduced
622
Closed
747

Sector Composition

Rank Sector Weight
1 Healthcare 20.28%
2 Financials 16.56%
3 Technology 13.74%
4 Consumer Discretionary 11.01%
5 Communication Services 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
2926
CALL
American International
AIG
$40.4B
$49K ﹤0.01%
+900
New +$46.4K
MDY icon
2927
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$48K ﹤0.01%
100
-500
-83% -$246K
TANH icon
2928
Tantech Holdings
TANH
$6.04M
$43K ﹤0.01%
7
NAT icon
2929
Nordic American Tanker
NAT
$1.31B
$41K ﹤0.01%
+15,941
New +$40K
DMAC icon
2930
DiaMedica Therapeutics
DMAC
$370M
$40K ﹤0.01%
10,031
-145,631
-94% -$557K
DNN icon
2931
Denison Mines
DNN
$3B
$37K ﹤0.01%
+24,963
New +$30.3K
LVO icon
2932
LiveOne
LVO
$62.8M
$36K ﹤0.01%
1,212
-13,361
-92% -$462K
VTVT icon
2933
vTv Therapeutics
VTVT
$130M
$36K ﹤0.01%
585
-6,221
-91% -$469K
LMT icon
2934
PUT
Lockheed Martin
LMT
$138B
$35K ﹤0.01%
+100
New +$36.2K
ZKIN icon
2935
ZK International Group
ZKIN
$61.3M
$34K ﹤0.01%
+1,756
New +$41.6K
FCX icon
2936
CALL
Freeport-McMoran
FCX
$96.4B
$33K ﹤0.01%
+1,000
New +$35.2K
ABBV icon
2937
CALL
AbbVie
ABBV
$442B
$32K ﹤0.01%
+300
New +$34.3K
CATX icon
2938
Perspective Therapeutics
CATX
$363M
$31K ﹤0.01%
+4,842
New +$33K
IGC icon
2939
IGC Pharma
IGC
$29.3M
$31K ﹤0.01%
+20,750
New +$33.5K
LRCX icon
2940
Lam Research
LRCX
$390B
$30K ﹤0.01%
530
-21,090
-98% -$1.28M
RMTI icon
2941
Rockwell Medical
RMTI
$27.9M
$25K ﹤0.01%
+383
New +$29.1K
CVX icon
2942
CALL
Chevron
CVX
$386B
$20K ﹤0.01%
+200
New +$19.9K
MBII
2943
DELISTED
Marrone Bio Innovations, Inc.
MBII
$20K ﹤0.01%
22,182
-132,468
-86% -$159K
ASHR icon
2944
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$19K ﹤0.01%
+500
New +$19.3K
BMY icon
2945
PUT
Bristol-Myers Squibb
BMY
$130B
$18K ﹤0.01%
+300
New +$19.8K
XWEL icon
2946
XWELL
XWEL
$8.36M
$18K ﹤0.01%
+618
New +$19.9K
WDC icon
2947
CALL
Western Digital
WDC
$151B
$17K ﹤0.01%
397
+265
+201% +$12.6K
KHC icon
2948
PUT
Kraft Heinz
KHC
$29.2B
$11K ﹤0.01%
+300
New +$11.3K
AAPL icon
2949
CALL
Apple
AAPL
$4.45T
-59,600
Closed -$8.16M
ABM icon
2950
ABM Industries
ABM
$2.83B
-51,209
Closed -$2.27M

Similar funds

Marshall Wace's Q3 2021 Portfolio in Review

As of Q3 2021, Marshall Wace held 3,709 positions worth $24.1B, up 8.9% from $22.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $2.04B of net new capital in Q3 2021, opening 1,117 new positions and adding to 953 existing holdings. Its largest new stake was SkinHealth Systems: 4,113,430 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Biogen, an estimated $210M trimmed.

  • Marshall Wace's largest Q3 2021 buy was SkinHealth Systems: 4,113,430 shares worth $107M.
  • Marshall Wace added most to Uber in Q3 2021, an estimated $127M increase.
  • Marshall Wace's biggest Q3 2021 reduction was Biogen, cutting an estimated $210M.
  • Marshall Wace fully exited Vipshop in Q3 2021, selling an estimated $58.7M.
  • Marshall Wace's ten largest holdings make up 10% of its $24.1B portfolio in Q3 2021.
  • Marshall Wace opened 1,117 new positions and closed 747 in Q3 2021.
  • Marshall Wace's portfolio value rose 8.9% quarter-over-quarter to $24.1B.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.